The reduction of the number of contaminating tumour cells by CD34+ cell selection might also play a role in survival by preventing the infusion of higher numbers of tumour cells that might overwhelm the immune system and result in relapse (Brenner et al, 1993). This evidence concerns the gene CD34 and neoplasm.